149
Participants
Start Date
June 28, 2011
Primary Completion Date
December 12, 2017
Study Completion Date
December 12, 2017
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine
laboratory biomarker analysis
Laser Surgery Care, New York
Montefiore Medical Center, The Bronx
Montefiore Medical Center, The Bronx
Wake Forest University Health Sciences, Winston-Salem
St. Jude's Children's Research Hospital, Memphis
Ruth M. Rothstein Core Center at Cook County Hospital, Chicago
Washington University School of Medicine, St Louis
Thomas Street Health Center, Houston
Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston
University of Colorado Cancer Center at UC Health Sciences Center, Aurora
UCLA Clinical AIDS Research and Education (CARE) Center, Los Angeles
Moores UCSD Cancer Center, La Jolla
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
Virginia Mason Medical Center, Seattle
Childrens Hospital Los Angeles, Los Angeles
John H. Stroger, Jr. Hospital of Cook County, Chicago
Fenway Community Health, Boston
Boston University Cancer Research Center, Boston
University of Puerto Rico Comprehensive Cancer Center, San Juan
National Cancer Institute (NCI)
NIH
The Emmes Company, LLC
INDUSTRY
University of Arkansas
OTHER
Merck Sharp & Dohme LLC
INDUSTRY
AIDS and Cancer Specimen Resource
OTHER
AIDS Malignancy Consortium
NETWORK